Takeda Pharmaceutical Company’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Hold |
1,475,121
| – | – | 5.13% | 3 |
|
|
2025
Q1 | $1.07M | Hold |
1,475,121
| – | – | 6.6% | 3 |
|
|
2024
Q4 | $1.42M | Hold |
1,475,121
| – | – | 5.33% | 3 |
|
|
2024
Q3 | $1.16M | Hold |
1,475,121
| – | – | 3.06% | 6 |
|
|
2024
Q2 | $1.4M | Hold |
1,475,121
| – | – | 0.6% | 8 |
|
|
2024
Q1 | $1.59M | Hold |
1,475,121
| – | – | 0.55% | 9 |
|
|
2023
Q4 | $811K | Buy |
+1,475,121
| New | +$811K | 0.25% | 11 |
|